{"pmid":32382463,"pmcid":"PMC7202588","title":"Rhabdomyolysis as a Presentation of 2019 Novel Coronavirus Disease.","text":["Rhabdomyolysis as a Presentation of 2019 Novel Coronavirus Disease.","An emerging viral infection is a global public health challenge. The development of modern, fast, and extensive transportation makes the outbreak hard to contain. Everyone is at risk, and the outbreak can rapidly turn into a pandemic crisis, like what we are currently facing for the 2019 novel coronavirus disease (COVID-19). Prompt diagnosis of the case is required to improve patients' prognosis and control of the outbreak. The common manifestations of COVID-19 include fever, cough, dyspnea, and malaise. However, patients may present with atypical symptoms that pose a diagnostic challenge. We report the first case of an elderly male who presented with rhabdomyolysis and later was diagnosed with COVID-19. Clinicians should be aware that rhabdomyolysis can be an initial presentation of COVID-19 or can occur at any time during the disease course. Patients with rhabdomyolysis should receive aggressive fluid administration to prevent acute kidney injury (AKI). However, COVID-19 patients are at risk of worsening oxygenation and acute hypoxemic respiratory failure from fluid overload. Therefore, cautious fluid administration is needed in COVID-19 patients with rhabdomyolysis.","Cureus","Suwanwongse, Kulachanya","Shabarek, Nehad","32382463"],"abstract":["An emerging viral infection is a global public health challenge. The development of modern, fast, and extensive transportation makes the outbreak hard to contain. Everyone is at risk, and the outbreak can rapidly turn into a pandemic crisis, like what we are currently facing for the 2019 novel coronavirus disease (COVID-19). Prompt diagnosis of the case is required to improve patients' prognosis and control of the outbreak. The common manifestations of COVID-19 include fever, cough, dyspnea, and malaise. However, patients may present with atypical symptoms that pose a diagnostic challenge. We report the first case of an elderly male who presented with rhabdomyolysis and later was diagnosed with COVID-19. Clinicians should be aware that rhabdomyolysis can be an initial presentation of COVID-19 or can occur at any time during the disease course. Patients with rhabdomyolysis should receive aggressive fluid administration to prevent acute kidney injury (AKI). However, COVID-19 patients are at risk of worsening oxygenation and acute hypoxemic respiratory failure from fluid overload. Therefore, cautious fluid administration is needed in COVID-19 patients with rhabdomyolysis."],"journal":"Cureus","authors":["Suwanwongse, Kulachanya","Shabarek, Nehad"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32382463","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.7759/cureus.7561","keywords":["ards","case report","corona virus","covid-19","covid-2019","novel corona virus","rhabdomyolysis"],"topics":["Case Report"],"weight":1,"_version_":1666267276715753473,"score":9.490897,"similar":[{"pmid":32447505,"title":"Pediatric COVID-19-associated rhabdomyolysis: a case report.","text":["Pediatric COVID-19-associated rhabdomyolysis: a case report.","COVID-19 is the illness caused by infection with the novel coronavirus SARS-CoV-2. Although myalgia is common in adults, it has not been noted as a common symptom in children. There have been a few reported cases of COVID-19-associated rhabdomyolysis in adults. This case report describes a 16-year-old boy who presented with fever, myalgias, mild shortness of breath with exertion, and dark-colored urine. COVID-19 PCR was positive. His initial creatinine kinase (CK) level was 427,656 U/L. Serum creatinine was normal for age. He was treated with isotonic intravenous fluids containing sodium bicarbonate to maintain urine output of 100-200 mL/h and urine pH > 7.0. His serum creatinine remained normal throughout the hospital stay and he was discharged on hospital day 12 with a CK of 6526 U/L. To our knowledge, no pediatric cases of COVID-19-associated rhabdomyolysis have been previously reported. Adult cases of rhabdomyolysis have been reported and a few reports have noted patients with elevated CK levels without rhabdomyolysis. Given this pediatric case of COVID-19-associated rhabdomyolysis, pediatric clinicians should be aware of this complication and manage fluids appropriately in order to prevent acute kidney injury.","Pediatr Nephrol","Gefen, Ashley M","Palumbo, Nancy","Nathan, Suresh K","Singer, Pamela S","Castellanos-Reyes, Laura J","Sethna, Christine B","32447505"],"abstract":["COVID-19 is the illness caused by infection with the novel coronavirus SARS-CoV-2. Although myalgia is common in adults, it has not been noted as a common symptom in children. There have been a few reported cases of COVID-19-associated rhabdomyolysis in adults. This case report describes a 16-year-old boy who presented with fever, myalgias, mild shortness of breath with exertion, and dark-colored urine. COVID-19 PCR was positive. His initial creatinine kinase (CK) level was 427,656 U/L. Serum creatinine was normal for age. He was treated with isotonic intravenous fluids containing sodium bicarbonate to maintain urine output of 100-200 mL/h and urine pH > 7.0. His serum creatinine remained normal throughout the hospital stay and he was discharged on hospital day 12 with a CK of 6526 U/L. To our knowledge, no pediatric cases of COVID-19-associated rhabdomyolysis have been previously reported. Adult cases of rhabdomyolysis have been reported and a few reports have noted patients with elevated CK levels without rhabdomyolysis. Given this pediatric case of COVID-19-associated rhabdomyolysis, pediatric clinicians should be aware of this complication and manage fluids appropriately in order to prevent acute kidney injury."],"journal":"Pediatr Nephrol","authors":["Gefen, Ashley M","Palumbo, Nancy","Nathan, Suresh K","Singer, Pamela S","Castellanos-Reyes, Laura J","Sethna, Christine B"],"date":"2020-05-25T11:00:00Z","year":2020,"_id":"32447505","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1007/s00467-020-04617-0","keywords":["children","coronavirus","creatine kinase","sars-cov-2"],"locations":["myalgia"],"topics":["Case Report"],"weight":1,"_version_":1667698385922031617,"score":345.1623},{"pmid":32197060,"title":"Rhabdomyolysis as Potential Late Complication Associated with COVID-19.","text":["Rhabdomyolysis as Potential Late Complication Associated with COVID-19.","We describe a patient in Wuhan, China, with severe acute respiratory syndrome coronavirus 2 infection who had progressive pulmonary lesions and rhabdomyolysis with manifestations of lower limb pain and fatigue. Rapid clinical recognition of rhabdomyolysis symptoms in patients with severe acute respiratory syndrome coronavirus 2 infection can be lifesaving.","Emerg Infect Dis","Jin, Min","Tong, Qiaoxia","32197060"],"abstract":["We describe a patient in Wuhan, China, with severe acute respiratory syndrome coronavirus 2 infection who had progressive pulmonary lesions and rhabdomyolysis with manifestations of lower limb pain and fatigue. Rapid clinical recognition of rhabdomyolysis symptoms in patients with severe acute respiratory syndrome coronavirus 2 infection can be lifesaving."],"journal":"Emerg Infect Dis","authors":["Jin, Min","Tong, Qiaoxia"],"date":"2020-03-21T11:00:00Z","year":2020,"_id":"32197060","source":"PubMed","week":"202012|Mar 16 - Mar 22","doi":"10.3201/eid2607.200445","keywords":["2019 novel coronavirus disease","covid-19","china","sars-cov-2","wuhan","respiratory diseases","rhabdomyolysis","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1666138490044153856,"score":287.02066},{"pmid":32414522,"title":"Weakness and elevated creatinine kinase as the initial presentation of coronavirus disease 2019 (COVID-19).","text":["Weakness and elevated creatinine kinase as the initial presentation of coronavirus disease 2019 (COVID-19).","COVID-19 is a global public health emergency with more than one million positive cases across the globe. COVID-19 has a multifaceted presentation. We are herein to report two cases of SARS-CoV-2 induced rhabdomyolysis with an initial presentation of weakness and elevated creatinine kinase (CK). Both patients had no respiratory symptoms, they only complained of generalized weakness and were found to have elevated CK. Routine chest X-ray showed bilateral infiltrates in both cases and subsequently reverse-transcription polymerase chain reaction (RT-PCR) for SARS-CoV-2 was positive. To the best of our knowledge, there was only one literature to date documented SARS-CoV-2 induced rhabdomyolysis as a late complication of COVID-19 patient. Our cases showed that elevated CK and rhabdomyolysis can be the sole initial presentation of patients with COVID-19 and total CK should be ordered in every patient on admission.","Am J Emerg Med","Chan, Kok Hoe","Farouji, Iyad","Abu Hanoud, Amany","Slim, Jihad","32414522"],"abstract":["COVID-19 is a global public health emergency with more than one million positive cases across the globe. COVID-19 has a multifaceted presentation. We are herein to report two cases of SARS-CoV-2 induced rhabdomyolysis with an initial presentation of weakness and elevated creatinine kinase (CK). Both patients had no respiratory symptoms, they only complained of generalized weakness and were found to have elevated CK. Routine chest X-ray showed bilateral infiltrates in both cases and subsequently reverse-transcription polymerase chain reaction (RT-PCR) for SARS-CoV-2 was positive. To the best of our knowledge, there was only one literature to date documented SARS-CoV-2 induced rhabdomyolysis as a late complication of COVID-19 patient. Our cases showed that elevated CK and rhabdomyolysis can be the sole initial presentation of patients with COVID-19 and total CK should be ordered in every patient on admission."],"journal":"Am J Emerg Med","authors":["Chan, Kok Hoe","Farouji, Iyad","Abu Hanoud, Amany","Slim, Jihad"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32414522","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.ajem.2020.05.015","keywords":["covid-19","elevated creatinine kinase","rhabdomyolysis","sars-cov-2"],"e_drugs":["Creatinine"],"topics":["Case Report"],"weight":1,"_version_":1666991242668408832,"score":278.03897},{"pmid":32313785,"pmcid":"PMC7164701","title":"A Review of Salivary Diagnostics and Its Potential Implication in Detection of Covid-19.","text":["A Review of Salivary Diagnostics and Its Potential Implication in Detection of Covid-19.","Saliva is an exocrine secretion produced from the salivary glands and has numerous functions, such as cleansing and protection of the oral cavity, antimicrobial effects and aids in digestion. Due to the speedy development in the field of salivaomics, saliva is now well accepted as a pool of biological markers that vary from changes in biochemicals, nucleic acids and proteins to the microflora. Saliva has an immense potential as a diagnostic fluid and offers an edge over other biological fluids as its collection method does not require invasive procedure, economical and is useful for monitoring systemic health. Development of sensitive and precise salivary diagnostic tools and the formulation of defined guidelines following meticulous testing will allow salivary diagnostics to be utilised as chair side tests for various oral and systemic diseases in the near future. The coronavirus disease (Covid-19) pandemic is the biggest challenge and global health crisis for the world since World War Two. Rapid and accurate diagnosis of Covid-19 is crucial in controlling the outbreak in the community and in hospitals. Nasopharyngeal and oropharyngeal swabs are the recommended specimen types for Covid-19 diagnostic testing. The collection of these specimen types requires close contact between healthcare workers and patients and poses a risk of transmission of the virus, causes discomfort and may cause bleeding, especially in patients with condition such as thrombocytopenia. Hence, nasopharyngeal or oropharyngeal swabs are not desirable for sequential monitoring of viral load. Saliva specimens can be obtained easily as the patient is asked to spit into a sterile bottle. The collection of saliva is non-invasive and greatly minimizes the exposure of healthcare workers to Covid-19. Saliva has a high consistency rate of greater than 90% with nasopharyngeal specimens in the detection of respiratory viruses, including coronaviruses. Saliva has also been used in screening respiratory viruses among hospitalized patients without pyrexia or respiratory symptoms. SARS-CoV can be detected in saliva at high titers. Salivary diagnostics is a dynamic field that is being incorporated as part of disease diagnosis, clinical monitoring of systemic health and to make significant clinical decisions for patient care. More research is required to analyze the potential diagnostic of Covid-19 in saliva to develop rapid chair side tests for the detection of Covid-19 and it is also pivotal to improve and develop successful strategies for prevention, especially for dentists and healthcare professionals who are involved in performing aerosol-generating procedures.","Cureus","Sri Santosh, Tatikonda","Parmar, Reshu","Anand, Hanish","Srikanth, Konkati","Saritha, Madham","32313785"],"abstract":["Saliva is an exocrine secretion produced from the salivary glands and has numerous functions, such as cleansing and protection of the oral cavity, antimicrobial effects and aids in digestion. Due to the speedy development in the field of salivaomics, saliva is now well accepted as a pool of biological markers that vary from changes in biochemicals, nucleic acids and proteins to the microflora. Saliva has an immense potential as a diagnostic fluid and offers an edge over other biological fluids as its collection method does not require invasive procedure, economical and is useful for monitoring systemic health. Development of sensitive and precise salivary diagnostic tools and the formulation of defined guidelines following meticulous testing will allow salivary diagnostics to be utilised as chair side tests for various oral and systemic diseases in the near future. The coronavirus disease (Covid-19) pandemic is the biggest challenge and global health crisis for the world since World War Two. Rapid and accurate diagnosis of Covid-19 is crucial in controlling the outbreak in the community and in hospitals. Nasopharyngeal and oropharyngeal swabs are the recommended specimen types for Covid-19 diagnostic testing. The collection of these specimen types requires close contact between healthcare workers and patients and poses a risk of transmission of the virus, causes discomfort and may cause bleeding, especially in patients with condition such as thrombocytopenia. Hence, nasopharyngeal or oropharyngeal swabs are not desirable for sequential monitoring of viral load. Saliva specimens can be obtained easily as the patient is asked to spit into a sterile bottle. The collection of saliva is non-invasive and greatly minimizes the exposure of healthcare workers to Covid-19. Saliva has a high consistency rate of greater than 90% with nasopharyngeal specimens in the detection of respiratory viruses, including coronaviruses. Saliva has also been used in screening respiratory viruses among hospitalized patients without pyrexia or respiratory symptoms. SARS-CoV can be detected in saliva at high titers. Salivary diagnostics is a dynamic field that is being incorporated as part of disease diagnosis, clinical monitoring of systemic health and to make significant clinical decisions for patient care. More research is required to analyze the potential diagnostic of Covid-19 in saliva to develop rapid chair side tests for the detection of Covid-19 and it is also pivotal to improve and develop successful strategies for prevention, especially for dentists and healthcare professionals who are involved in performing aerosol-generating procedures."],"journal":"Cureus","authors":["Sri Santosh, Tatikonda","Parmar, Reshu","Anand, Hanish","Srikanth, Konkati","Saritha, Madham"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32313785","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.7759/cureus.7708","keywords":["cost effective","non invasive","novel corona virus","safe","salivary diagnostics"],"topics":["Diagnosis"],"weight":1,"_version_":1666138493538009089,"score":163.15053},{"pmid":32434806,"title":"Management of acute kidney injury in COVID-19.","text":["Management of acute kidney injury in COVID-19.","Acute kidney injury has been reported in as many as 29% of COVID-19 patients. Reported risk factors include elevated baseline serum creatinine, elevated blood urea nitrogen, acute kidney injury, proteinuria, and hematuria. Suspected causes include sepsis and acute tubular necrosis resulting from renal hypoperfusion, cytokine release syndrome, direct viral invasion, renal medullary hypoxia secondary to alveolar damage, rhabdomyolysis, and cardiorenal syndrome due to viral myocarditis.","Cleve Clin J Med","Hassanein, Mohamed","Thomas, George","Taliercio, Jonathan","32434806"],"abstract":["Acute kidney injury has been reported in as many as 29% of COVID-19 patients. Reported risk factors include elevated baseline serum creatinine, elevated blood urea nitrogen, acute kidney injury, proteinuria, and hematuria. Suspected causes include sepsis and acute tubular necrosis resulting from renal hypoperfusion, cytokine release syndrome, direct viral invasion, renal medullary hypoxia secondary to alveolar damage, rhabdomyolysis, and cardiorenal syndrome due to viral myocarditis."],"journal":"Cleve Clin J Med","authors":["Hassanein, Mohamed","Thomas, George","Taliercio, Jonathan"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32434806","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.3949/ccjm.87a.ccc034","e_drugs":["Creatinine","Nitrogen","Urea"],"topics":["Treatment"],"weight":1,"_version_":1667521393833541633,"score":157.94896}]}